Epic to launch medical billing unit later in 2017

Electronic health record giant Epic is now expanding into medical billing space, according to a new job listing posted on its website.

The company is seeking a medical biller with knowledge of Medicaid, Medicare and other insurance guidelines and familiarity with medical terminology and remittance/denial codes. A background or certification with medical coding would be preferred.

“Our goal is to simplify the payment process by helping Epic organizations with the complexities of submitting claims and posting payments. Attention to detail is vital as you'll be posting payments and denials; reconciling payment files, claims, and statements; resolving posting errors; and calling payers to follow up on outstanding or unpaid claims,” the ad says.

Epic spokesperson Meghan Roh said the company’s presence makes it “well positioned” to “share our best practices take on some of the billing work, and associated IT functions, for our Resolute Professional Billing customers.”

“Launching later this year, this new offering will help those who are struggling to scale their billing services, looking to keep a light operational footprint, or those who are just simply hoping to step away from revenue cycle management,” she said.

Epic has been the leader in EHR market share among hospitals with 200 or fewer beds, while trailing rivals Cerner and McKesson by other measures. Its Resolute Billing software was awarded Best of KLAS in the patient accounting & patient management category earlier this year.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.